Susan M. Stalnecker's Insider Trades & SAST Disclosures
Susan M. Stalnecker's most recent trade in Leidos Holdings Inc was a trade of 8,278 Common Stock done at an average price of $132.3 . Disclosure was reported to the exchange on Feb. 18, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Susan M. Stalnecker.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Leidos Holdings Inc | Susan M. Stalnecker | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 132.26 per share. | 18 Feb 2025 | 8,278 | 20,985 (0%) | 0% | 132.3 | 1,094,848 | Common Stock |
| Leidos Holdings Inc | Susan M. Stalnecker | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Feb 2025 | 4,070 | 0 | - | - | Stock Option (Right to Buy) | |
| Leidos Holdings Inc | Susan M. Stalnecker | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 63.08 per share. | 18 Feb 2025 | 4,070 | 19,730 (0%) | 0% | 63.1 | 256,736 | Common Stock |
| Leidos Holdings Inc | Susan M. Stalnecker | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 75.02 per share. | 18 Feb 2025 | 3,345 | 23,075 (0%) | 0% | 75.0 | 250,942 | Common Stock |
| Leidos Holdings Inc | Susan M. Stalnecker | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Feb 2025 | 3,345 | 0 | - | - | Stock Option (Right to Buy) | |
| Leidos Holdings Inc | Susan M. Stalnecker | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 79.45 per share. | 18 Feb 2025 | 2,296 | 29,263 (0%) | 0% | 79.4 | 182,417 | Common Stock |
| Leidos Holdings Inc | Susan M. Stalnecker | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Feb 2025 | 2,296 | 0 | - | - | Stock Option (Right to Buy) | |
| Leidos Holdings Inc | Susan M. Stalnecker | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 103.90 per share. | 18 Feb 2025 | 2,123 | 25,198 (0%) | 0% | 103.9 | 220,580 | Common Stock |
| Leidos Holdings Inc | Susan M. Stalnecker | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Feb 2025 | 2,123 | 0 | - | - | Stock Option (Right to Buy) | |
| Leidos Holdings Inc | Susan M. Stalnecker | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 104.06 per share. | 18 Feb 2025 | 1,769 | 26,967 (0%) | 0% | 104.1 | 184,082 | Common Stock |
| Leidos Holdings Inc | Susan M. Stalnecker | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Feb 2025 | 1,769 | 0 | - | - | Stock Option (Right to Buy) | |
| Bioventus Inc - Ordinary S... | Susan M. Stalnecker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2024 | 26,493 | 26,493 | - | - | Restricted Stock Units | |
| Bioventus Inc - Ordinary S... | Susan M. Stalnecker | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jun 2024 | 30,400 | 0 | - | - | Restricted Stock Units | |
| Bioventus Inc - Ordinary S... | Susan M. Stalnecker | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jun 2024 | 30,400 | 79,464 (0%) | 0% | 0 | Class A Common Stock | |
| Leidos Holdings Inc | Susan M. Stalnecker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2024 | 1,179 | 1,179 | - | - | Stock Option (Right to Buy) | |
| Leidos Holdings Inc | Susan M. Stalnecker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2024 | 912 | 15,660 (0%) | 0% | 0 | Common Stock | |
| Leidos Holdings Inc | Susan M. Stalnecker | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 May 2024 | 4,788 | 0 | - | - | Stock Option (Right to Buy) | |
| Leidos Holdings Inc | Susan M. Stalnecker | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 52.70 per share. | 02 May 2024 | 4,788 | 19,536 (0%) | 0% | 52.7 | 252,328 | Common Stock |
| Leidos Holdings Inc | Susan M. Stalnecker | Director | Sale of securities on an exchange or to another person at price $ 141.97 per share. | 02 May 2024 | 3,014 | 14,748 (0%) | 0% | 142.0 | 427,909 | Common Stock |
| Leidos Holdings Inc | Susan M. Stalnecker | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 142.19 per share. | 02 May 2024 | 1,774 | 17,762 (0%) | 0% | 142.2 | 252,245 | Common Stock |
| Bioventus Inc - Ordinary S... | Susan M. Stalnecker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2023 | 30,400 | 30,400 | - | - | Restricted Stock Units | |
| Bioventus Inc - Ordinary S... | Susan M. Stalnecker | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jun 2023 | 16,648 | 49,064 (0%) | 0% | 0 | Class A Common Stock | |
| Bioventus Inc - Ordinary S... | Susan M. Stalnecker | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jun 2023 | 16,648 | 0 | - | - | Restricted Stock Units | |
| Leidos Holdings Inc | Susan M. Stalnecker | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 39.70 per share. | 12 May 2023 | 5,193 | 17,382 (0%) | 0% | 39.7 | 206,162 | Common Stock |
| Leidos Holdings Inc | Susan M. Stalnecker | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 May 2023 | 5,193 | 0 | - | - | Stock Option (Right to Buy) | |
| Leidos Holdings Inc | Susan M. Stalnecker | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 78.27 per share. | 12 May 2023 | 2,634 | 14,748 (0%) | 0% | 78.3 | 206,163 | Common Stock |
| Leidos Holdings Inc | Susan M. Stalnecker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2023 | 2,296 | 2,296 | - | - | Stock Option (Right to Buy) | |
| Leidos Holdings Inc | Susan M. Stalnecker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2023 | 1,574 | 12,189 (0%) | 0% | 0 | Common Stock | |
| Bioventus Inc - Ordinary S... | Susan M. Stalnecker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2022 | 16,648 | 16,648 | - | - | Restricted Stock Units | |
| Leidos Holdings Inc | Susan M. Stalnecker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 May 2022 | 1,784 | 1,784 | - | - | Stock Option (Right to Buy) | |
| Leidos Holdings Inc | Susan M. Stalnecker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 May 2022 | 1,106 | 10,615 (0%) | 0% | 0 | Common Stock | |
| Bioventus Inc - Ordinary S... | Susan M. Stalnecker | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2022 | 23,416 | 0 | - | - | Restricted Stock Units | |
| Bioventus Inc - Ordinary S... | Susan M. Stalnecker | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2022 | 23,416 | 32,416 (0%) | 0% | - | Class A Common Stock | |
| Bioventus Inc - Ordinary S... | Susan M. Stalnecker | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2022 | 9,000 | 9,000 (0%) | 0% | - | Class A Common Stock | |
| Bioventus Inc - Ordinary S... | Susan M. Stalnecker | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2022 | 9,000 | 0 | - | - | Restricted Stock Units | |
| Leidos Holdings Inc | Susan M. Stalnecker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 May 2021 | 2,123 | 2,123 | - | - | Stock Option (Right to Buy) | |
| Leidos Holdings Inc | Susan M. Stalnecker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 May 2021 | 1,059 | 9,509 (0%) | 0% | 0 | Common Stock | |
| Bioventus Inc - Ordinary S... | Susan M. Stalnecker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2021 | 23,416 | 23,416 | - | - | Restricted Stock Units | |
| Bioventus Inc - Ordinary S... | Susan M. Stalnecker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2021 | 9,000 | 9,000 | - | - | Restricted Stock Units |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges